Healthcare Companies Counter Investor Worries Over Wegovy Effect

Healthcare companies who profit from treating obese and overweight patients are trying to convince investors that powerful new weight-loss drugs won't shrink their businesses.
Reuters Health Information

source https://www.medscape.com/s/viewarticle/997800?src=rss

Comments

Popular posts from this blog

New AAFP practice guideline sets blood pressure targets for adults with hypertension